EZH2 and myeloproliferative neoplasm: We note that aUPD for other regions has not been associated with a specific mutational target in all cases, for example, we found that only 9 of 12 MDS/MPN cases with aUPD7q had EZH2 mutations, with the target of the remaining 3 cases remaining unclear.2